+588.9%
RVMD vs BBIO
+42.7%
+546.1%
-56.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.2% | -0.1% | +0.3% | +0.2% |
| 7D | -3.0% | -3.2% | +0.2% | -2.2% |
| 30D | -0.7% | -13.6% | +12.9% | +2.9% |
| 3M | +36.5% | +7.2% | +29.3% | +33.7% |
| 6M | +104.6% | +1.5% | +103.1% | +103.1% |
| YTD | +155.8% | -5.3% | +161.1% | +156.0% |
| 1Y | +340.7% | +37.7% | +303.0% | +300.7% |
| 3Y | +519.9% | +153.9% | +366.0% | +366.1% |
| All | +588.9% | +42.7% | +546.1% | +285.9% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling